The subsidiary of Baicheng Pharmaceuticals, Saimo Pharmaceuticals, has obtained approval for the listing of the improved new drug "Levetiracetam Extended-Release Granules".

Recently, Zhejiang Saimo Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Baicheng Medicine, has obtained approval from the National Medical Products Administration for the listing of its improved new chemical drug, Levosi Tan sustained-release granules. This is the first improved new drug approved for Baicheng Medicine, marking a milestone breakthrough for the company in the field of improved new drug research and development.